| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 6941 | 2011 |
| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 1710 | 2012 |
| Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes … SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly, CD Joyner, CB Granger, ... The Lancet 376 (9748), 1233-1243, 2010 | 939 | 2010 |
| Dose comparisons of clopidogrel and aspirin in acute coronary syndromes Current–Oasis 7 Investigators New England Journal of Medicine 363 (10), 930-942, 2010 | 850 | 2010 |
| Early versus delayed invasive intervention in acute coronary syndromes SR Mehta, CB Granger, WE Boden, PG Steg, JP Bassand, DP Faxon, ... New England Journal of Medicine 360 (21), 2165-2175, 2009 | 768 | 2009 |
| Facilitated PCI in patients with ST-elevation myocardial infarction SG Ellis, M Tendera, MA de Belder, AJ van Boven, P Widimsky, ... New England Journal of Medicine 358 (21), 2205-2217, 2008 | 762 | 2008 |
| Darapladib for preventing ischemic events in stable coronary heart disease Stability Investigators New England Journal of Medicine 370 (18), 1702-1711, 2014 | 368 | 2014 |
| Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial ML O’Donoghue, E Braunwald, HD White, DL Steen, MA Lukas, E Tarka, ... Jama 312 (10), 1006-1015, 2014 | 288 | 2014 |
| Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ... The Lancet Neurology 11 (6), 503-511, 2012 | 269 | 2012 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 249 | 2018 |
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data M Gyöngyösi, W Wojakowski, P Lemarchand, K Lunde, M Tendera, ... Circulation research 116 (8), 1346-1360, 2015 | 221 | 2015 |
| RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary … PG Steg, SR Mehta, JW Jukema, GYH Lip, CM Gibson, F Kovar, P Kala, ... European heart journal 32 (20), 2541-2554, 2011 | 183 | 2011 |
| Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial AM Lincoff, JC Tardif, GG Schwartz, SJ Nicholls, L Rydén, B Neal, ... Jama 311 (15), 1515-1525, 2014 | 161 | 2014 |
| Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study M Gyöngyösi, I Lang, M Dettke, G Beran, S Graf, H Sochor, N Nyolczas, ... Nature Reviews Cardiology 6 (1), 70, 2009 | 145 | 2009 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 116 | 2018 |
| Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences N Pavo, S Charwat, N Nyolczas, A Jakab, Z Murlasits, J Bergler-Klein, ... Journal of molecular and cellular cardiology 75, 12-24, 2014 | 82 | 2014 |
| Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial … N Nyolczas, M Gyöngyösi, G Beran, M Dettke, S Graf, H Sochor, G Christ, ... American heart journal 153 (2), 212. e1-212. e7, 2007 | 58 | 2007 |
| Multislice computed tomographic coronary angiography for quantitative assessment of culprit lesions in acute coronary syndromes T Benedek, M Gyöngyösi, I Benedek Canadian Journal of Cardiology 29 (3), 364-371, 2013 | 47 | 2013 |
| Single‐pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study JM Neutel, G Mancia, HR Black, B Dahlöf, H Defeo, L Ley, R Vinisko, ... The Journal of Clinical Hypertension 14 (4), 206-215, 2012 | 36 | 2012 |
| Plaque quantification by coronary CT and intravascular ultrasound identifies a low CT density core as a marker of plaque instability in acute coronary syndromes T Benedek, B Jako, I Benedek International heart journal 55 (1), 22-28, 2014 | 29 | 2014 |
